Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity
This study has suspended participant recruitment.
(interim analysis)
Sponsor:
Milton S. Hershey Medical Center
Information provided by (Responsible Party):
Leah Cream, Milton S. Hershey Medical Center
ClinicalTrials.gov Identifier:
NCT00886535
First received: April 22, 2009
Last updated: January 8, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has suspended participant recruitment. |
|---|---|
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |